LAKE FOREST, Ill., July 15, 2015 /PRNewswire/ -- Hospira, Inc.
(NYSE: HSP), the world's leading provider of injectable drugs and
infusion technologies, and a global leader in biosimilars, will
release its second-quarter 2015 results on Wednesday, July 29, 2015, before the U.S. stock
market open. Given the company's pending merger with Pfizer Inc.,
Hospira will not be holding a conference call.
Hospira intends to file its Quarterly Report on Form 10-Q for
the fiscal second quarter ended June 30,
2015 with the U.S. Securities and Exchange Commission (SEC)
on the same day. As is the company's standard practice, both
documents will be accessible in the Investor Relations section of
Hospira's website at www.hospirainvestor.com.
About Hospira
Hospira, Inc. is the world's
leading provider of injectable drugs and infusion technologies, and
a global leader in biosimilars. Through its broad, integrated
portfolio, Hospira is uniquely positioned to Advance
Wellness™ by improving patient and caregiver safety while reducing
healthcare costs. The company is headquartered in Lake Forest,
Ill. Learn more at www.hospira.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/hospira-to-announce-second-quarter-2015-results-on-july-29-2015-300113987.html
SOURCE Hospira, Inc.